NasdaqGM - Nasdaq Real Time Price • USD
Atai Life Sciences N.V. (ATAI)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 7:54 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-84,118.0000
-84,118.0000
-104,467.0000
-63,246.0000
-20,766.0000
Investing Cash Flow
-53,295.0000
-53,295.0000
-86,848.0000
-81,276.0000
-28,271.0000
Financing Cash Flow
-8,355.0000
-8,355.0000
20,785.0000
409,862.0000
113,052.0000
End Cash Position
45,034.0000
45,034.0000
190,613.0000
362,266.0000
97,246.0000
Capital Expenditure
-590.0000
-590.0000
-1,024.0000
-1,128.0000
-59.0000
Issuance of Capital Stock
--
--
600.0000
409,884.0000
82,439.0000
Issuance of Debt
--
--
15,000.0000
1,588.0000
32,503.0000
Free Cash Flow
-84,708.0000
-84,708.0000
-105,491.0000
-64,374.0000
-20,825.0000
12/31/2020 - 6/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYBN Cybin Inc.
0.3460
-2.54%
MNMD Mind Medicine (MindMed) Inc.
8.52
+0.71%
CYBN.NE Cybin Inc.
0.4600
-4.17%
SEEL Seelos Therapeutics, Inc.
0.2856
-5.12%
GHRS GH Research PLC
10.50
-5.23%
MDMA.CN Pharmala Biotech Holdings Inc.
0.2200
-4.35%
IGXT IntelGenx Technologies Corp.
0.1666
+11.09%
BTAI BioXcel Therapeutics, Inc.
2.6100
-3.69%
FGEN FibroGen, Inc.
1.0200
+3.63%
TCON TRACON Pharmaceuticals, Inc.
1.7900
-5.29%